Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

OBJECTIVES: Evaluation of long-term safety of rituximab in rheumatoid arthritis (RA). METHODS: Pooled observed case analysis of data from patients with moderate-to-severe, active RA treated with rituximab in a global clinical trial programme. RESULTS: As of September 2010, 3194 patients had received...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vollenhoven, Ronald F, Emery, Paul, Bingham, Clifton O, Keystone, Edward C, Fleischmann, Roy M, Furst, Daniel E, Tyson, Nicola, Collinson, Neil, Lehane, Patricia B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756452/
https://www.ncbi.nlm.nih.gov/pubmed/23136242
http://dx.doi.org/10.1136/annrheumdis-2012-201956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756452/
https://www.ncbi.nlm.nih.gov/pubmed/23136242
http://dx.doi.org/10.1136/annrheumdis-2012-201956

Ejemplares similares